Cite
MLA Citation
F E L van den Elzen et al.. “OS05.7.A Absence of severe hematological toxicity during first line treatment predicts low chance on severe toxicity during second line alkylating chemotherapy in glioblastoma.” Neuro-oncology, vol. 23, 2021, p. ii8. http://access.bl.uk/ark:/81055/vdc_100140625908.0x000020